return equiti ttm
fourth-quart review midsingle-digit organ growth expect
adjust ep increas year-over-year slightli consensu estim
revenu increas organ acquisit foreign currenc
billion slightli consensu estim billion segment
organ revenu increas life scienc diagnost dental
environment appli solut
gross margin contract basi point year-over-year adjust oper
expens percentag sale contract basi point result
factor adjust oper margin contract basi point year-over-year
oper margin contract basi point year-over-year fourth
quarter manag comment margin would roughli basi
point year-over-year fourth quarter exclud headwind foreign currenc
translat tariff
manag introduc first quarter adjust ep guidanc rang
translat flat growth year-over-year consensu estim
releas manag forecast core revenu growth first quarter
full year manag expect adjust ep
midpoint slightli consensu estim releas
midpoint full-year rang repres growth manag indic
expect core revenu growth full year foreign currenc translat
expect present approxim million revenu headwind first quarter
adjust ep impact million headwind full year
manag note compani china busi report double-digit growth
quarter mark eighth straight quarter second consecut year double-
digit growth region tariff expect million increment impact
revenu versu
remain track complet spin-off compani dental segment
second half manag said continu monitor businesss readi
stand-alon entiti segment report organ revenu growth basi
point adjust oper margin expans year-over-year fourth quarter
diversifi global scienc technolog compani design manufactur market divers
line industri healthcare-rel product four strateg platforms-lif scienc diagnost dental
environment appli solut recur revenu account sale product
produc sold world-wide north america sale europ asia/australia
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
forecast shown exhibit slightli lower estim primarili updat currenc
assumpt particularli first second quarter
valuat conclus trade time adjust ep estim compar
diversifi industri peer group averag time base estim premium line
recent histor averag expect share appreci line annual earn growth forecast
midsingle-digit high-single-digit rang potenti low-double-digit growth includ futur acquisit
expect low- midteen ep growth includ accret futur acquisit longer term
view premier diversifi industri compani well-defin busi strategi effici oper
philosophi believ continu yield superior long-term financi perform rel peer group
compani strength includ proven manag team divers end-market custom geograph presenc
histor superior sale growth oper margin cash flow gener return equiti compar
diversifi industri invest demonstr acquisit record continuous-improv cultur root
danah busi system db expect share continu rise solid execut continu earn growth
result maintain outperform rate
segment detail growth rate refer section core growth rate
life scienc fourth-quart sale revenu increas year-over-year includ high-single-digit
growth beckman life scienc midsingle-digit growth lecia microsystem high-single-digit growth sciex
high-single-digit growth pall acquir april report revenu growth midteen
segment adjust oper margin contract basi point driven foreign currenc impact
growth invest quarter
diagnost fourth-quart sale revenu increas year-over-year includ midsingle-digit growth
beckman diagnost high-single-digit growth radiomet midsingle-digit growth lecia biosystem
double-digit growth cepheid segment face difficult comparison first quarter cepheid
particularli strong first quarter driven flu season segment adjust oper margin contract
basi point fourth quarter core oper margin expand basi point
dental fourth-quart sale revenu increas basi point adjust oper margin
expans year-over-year fourth quarter
environment appli solut fourth-quart sale revenu increas driven midsingle-
digit growth product identif high-single-digit growth videojet low-single-digit declin packag
midsingle-digit growth water qualiti segment adjust oper margin contract basi point year-over-
year expand basi point organ
op figur billion except per-shar consensu figur immedi prior earn releasesourc factset william blair estimatesdanah forecastwb forecast william blair
life revenu oper diagnosticsrevenu revenu oper revenu oper environment appli solutionsrevenu revenu oper compani dataiii dentalcompon platform sale growth william blair
balanc sheet cash flow fourth quarter gener free cash flow billion year-over-
year result free-cash-flow-to-adjusted-net-incom convers ratio consolid balanc sheet
modestli leverag debt-to-capit ratio compani investor day decemb note danah
taken debt level around time ebitda financ acquisit past given healthi cash flow gener
abil de-lev quickli number would unreason look forward translat roughli billion
capac opportun head
made one major acquisit last month april acquir integr dna technolog
purchas price billion provid high-valu consum genom applic molecular
biolog qpcr next gener sequenc synthet biolog gene edit molecular diagnost idt primari busi
manufactur high-qual custom dna rna oligonucleotid purchas price repres multipl
time estim ebitda million expect gener revenu greater
million anticip busi grow core revenu double-digit-plu rate annual
manag expect earn double-digit rang year six acquisit expect accret adjust
ep
follow exhibit highlight major acquisit recent year
datetargetplatformoverviewestim price million sale prior year million price/salesfeb technologywith headquart westlak ohio radiomet develop manufactur distribut technolog advanc critic care test system blood ga electrolyt metabolit compani offer complet solut complex process blood technologyth acquisit gendex mark entri dental busi gendex divis dentspli inc headquart de plain illinoi gendex lead manufactur dental imag product includ intra-or technologykaltenbach voight gmbh headquart biberach germani world-wide leader design manufactur sale dental equip includ handpiec treatment unit diagnost system laboratori ontario canada trojan inc lead water treatment technolog compani largest instal base ultraviolet water treatment system oper around rmselectron testwith headquart cleveland ohio cardin radiat manag servic provid solut maintain safe regulatory-compli facil medic imag therapi print plcproduct identificationlinx headquart st ive cambridgeshir uk major player global code mark industri suppli focus rang industri non-contact code mark equip base inkjet laser testwith primari oper unit kingdom austria produc sell comprehens array electr measur solut use commerci industri medic technologywith primari oper charlott north carolina newberg oregon pelton manufactur sell broad rang dental equip includ treatment unit light steril cabinetri dental microsystemsmed technologybas germani leica microsystem lead global design produc innov high- precis imag system use life scienc relat networkselectron testbas rockvil maryland visual network lead provid network test applic perform manag solut becom part fluke network busi technologywith headquart newport beach california sybron dental specialti manufactur high technolog dental dental implant infect prevent product dental restor orthodont endodont infect prevent systemsmed technologyvis system base australia manufactur market autom instrument biochem reagent detect cancer infecti diseas compani possess valuabl intellectu properti associ instrument reagent glen allen virginia chemtreat manufactur water treatment product chemic industri water treatment applic testbas beaverton oregon tektronix lead supplier test measur monitor product enabl design manufactur manag next-gener global commun network comput advanc technolog focu commun comput semiconductor consum electron military/aerospac educ industri group plcmedic technologygenetix headquart new milton hampshir uk provid scientist clinician solut imag intellig imag analysi facilit develop pharmaceut biotherapeut mainstream research clinic sciex md inc medic technologycalifornia-bas ab sciex lead design manufactur mass spectromet instrument use indentifi quantifi specif molecul specif sampl typic applic includ proteom research drug develop food environment safeti test diagnost test molecular devic suppli high-perform bioanalytical instrument system consum acceler improv research product effect life scienc research drug instrumentselectron testohio-bas keithley instrument design develop manufactur market complex electron instrument system gear special need engin electron manufactur academ institut research product develop high-perform product test process idwith headquart ghent belgium eskoartwork full-servic solut provid digit packag design product market eskoartwork suit softwar hardwar solut help custom reduc digit design cycl time ensur integr throughout packag materi suppli chain coulter inc life scienc diagnosticsbas brea california beckman coulter design manufactur market laboratori system includ instrument chemistri softwar suppli biomed laboratori need product use rang applic pioneer medic research drug discoveri diagnost system found hospit physician incorporatedproduct idx-rit global leader color scienc technolog compani includ design industri color leader panton llc develop manufactur market support innov color solut measur system softwar color standard inc life scienc diagnosticsbas chatsworth california iri inc lead global vitro diagnost compani focus product analyz particl live cell form structur morpholog varieti bodi biocaredentalheadquart switzerland nobel biocar manufactur dental implant cad/cam-bas prosthet restor aesthet dental medic productslif scienc diagnosticsheadquart cincinnati oh devicor global leader anatom patholog laboratori solut instrument special breast biopsi insutr consum microbiologylif scienc diagnosticsth microbiolog piec siemen healthcar busi establish leader microbi identif antibiot sensit test id/ast sciencespal lead provid filtrat separ purif solut remov contamin separ substanc varieti solid liquid lead innov global molecular diagnost compani develop manufactur market accur easi use molecular system sciencesphenomenex manufactur distributor high-valu consum separ scienc compani lead player proprietari chromatographi dna life sciencesidt provid high-valu consum genom applic molecular biolog qpcr next gener sequenc synthet biolog gene edit molecular compani report william blair estimateschronolog major acquisit william blair
incom wb tax net ni share ep cont ebitda saleslif appli oper appli segment oper margin adjust amort expens sourc compani data william blair estimatesdanah varianc tabl william blair
thousand except per-shar item fiscal year end statement net good ex restr oper intang expens tax net discontinu avail amort intang after-tax non-recurring expens net epsaverag dilut share dilut ep continu intang incom dilut tax tax sale net good ex restr oper net rate net good ex restr oper net dilut compani data william blair estim william blair
analysisseg saleslif environment appli total net segment sale growthlif appli segment total segment saleslif appli segment segment oper profitlif environment appli total segment total adjust oper report segment oper profit marginlif appli total segment oper profitlif appli segment oper increment oper marginlif appli increment oper increment oper marginlif appli increment oper compani data william blair estim thousand except per share import disclosur
